{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:10:11Z","timestamp":1740107411501,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-10621-x","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T12:02:13Z","timestamp":1706270533000},"page":"5461-5463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast cancer: evaluating the axilla before, during, and after therapy\u2014new challenges"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-5113","authenticated-orcid":false,"given":"Petra","family":"Steyerova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orit","family":"Kaidar-Person","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Pinker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dubsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"key":"10621_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.breast.2023.03.001","volume":"69","author":"M Banys-Paluchowski","year":"2023","unstructured":"Banys-Paluchowski M, Rubio IT, Ditsch N, Krug D, Gentilini OD, K\u00fchn T (2023) Real de-escalation or escalation in disguise? Breast 69:249\u2013257","journal-title":"Breast"},{"key":"10621_CR2","doi-asserted-by":"crossref","unstructured":"Gentilini OD, Botteri E, Sangalli C et al (2023) Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol  9(11):1557\u20131564","DOI":"10.1001\/jamaoncol.2023.3759"},{"issue":"6","key":"10621_CR3","doi-asserted-by":"publisher","first-page":"e210891","DOI":"10.1001\/jamasurg.2021.0891","volume":"156","author":"S Samiei","year":"2021","unstructured":"Samiei S, Simons JM, Engelen SME et al (2021) Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis. JAMA Surg 156(6):e210891","journal-title":"JAMA Surg"},{"key":"10621_CR4","doi-asserted-by":"publisher","first-page":"102085","DOI":"10.1016\/j.eclinm.2023.102085","volume":"61","author":"O Kaidar-Person","year":"2023","unstructured":"Kaidar-Person O, Pfob A, Gentilini O et al (2023) The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus. EClinicalMedicine 61:102085","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10621_CR5","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(20)30580-5","volume":"22","author":"P Dubsky","year":"2021","unstructured":"Dubsky P, Pinker K, Cardoso F et al (2021) Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Lancet Oncol 22(1):e18\u2013e28","journal-title":"Lancet Oncol"},{"issue":"2","key":"10621_CR6","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1634\/theoncologist.2019-0427","volume":"25","author":"MA Marino","year":"2020","unstructured":"Marino MA, Avendano D, Zapata P, Riedl CC, Pinker K (2020) Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools. Oncologist 25(2):e231\u2013e242","journal-title":"Oncologist"},{"issue":"9","key":"10621_CR7","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1007\/s00330-015-3683-6","volume":"25","author":"TP Farrell","year":"2015","unstructured":"Farrell TP, Adams NC, Stenson M et al (2015) The Z0011 Trial: is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients? Eur Radiol 25(9):2682\u20132687","journal-title":"Eur Radiol"},{"issue":"4","key":"10621_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/SLA.0000000000004356","volume":"273","author":"S Samiei","year":"2021","unstructured":"Samiei S, de Mooij CM, Lobbes MBI, Keymeulen KBMI, van Nijnatten TJA, Smidt ML (2021) Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis. Ann Surg 273(4):694\u2013700","journal-title":"Ann Surg"},{"issue":"10265","key":"10621_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","volume":"396","author":"J Cortes","year":"2020","unstructured":"Cortes J, Cescon DW, Rugo HS et al (2020) Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial. Lancet 396(10265):1817\u20131828","journal-title":"Lancet"},{"issue":"1","key":"10621_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(22)00694-5","volume":"24","author":"SRD Johnston","year":"2023","unstructured":"Johnston SRD, Toi M, O\u2019Shaughnessy J et al (2023) Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol 24(1):77\u201390","journal-title":"Lancet Oncol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-10621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-10621-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-10621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T07:10:13Z","timestamp":1721200213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-10621-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":10,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["10621"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-10621-x","relation":{},"ISSN":["1432-1084"],"issn-type":[{"type":"electronic","value":"1432-1084"}],"subject":[],"published":{"date-parts":[[2024,1,26]]},"assertion":[{"value":"8 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor is Petra Steyerova,","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.Prof. Katja Pinker is member of the European Radiology Scientific Editorial Board, breast section. She has not taken part in the review or selection process of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 commentary","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}